Paediatric cardiac anaesthesia in the UK - Current controversies

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 38, Issue 8, 2003, Pages 506-513

  Booker, P D ^a   Davis, A J ^a  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; APROTININ; CLONIDINE; CODEINE PHOSPHATE; DEXAMETHASONE; DICLOFENAC; EMLA; FENTANYL; METHYLPREDNISOLONE; MIDAZOLAM; MORPHINE; OPIATE; PARACETAMOL; ROCURONIUM; STEROID; TETRACAINE; VECURONIUM;

ANALGESIA; ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; BALANCED ANESTHESIA; BLEEDING; CARDIOPULMONARY BYPASS; CENTRALIZATION; CHILD; CONGENITAL HEART DISEASE; HEART TAMPONADE; HUMAN; INFORMED CONSENT; INTENSIVE CARE; NEWBORN; PEDIATRIC ANESTHESIA; PEDIATRIC HOSPITAL; PREOPERATIVE EVALUATION; RESOURCE ALLOCATION; REVIEW; SPINAL CORD ISCHEMIA; STEROID THERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAINING; ULTRAFILTRATION; UNITED KINGDOM;

ANESTHESIA; ANESTHESIOLOGY; APROTININ; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; GREAT BRITAIN; HEMOSTATICS; HUMANS; INFORMED CONSENT; PEDIATRICS; POSTOPERATIVE CARE; ULTRAFILTRATION;

EID: 0041929454     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41188     Document Type: Review

References (55)

1. Bristol Royal Infirmary Inquiry. http://www.bristol-inquiry.org/2001
2. Spiegelhalter DJ. Mortality and volume of cases in paediatric cardiac surgery: retrospective study based on routinely collected data. Br Med J 2001; 323: 1-5
3. Hannan EL, Racz M, Kavey RE, et al. Pediatric cardiac surgery: the effect of hospital and surgeon volume on in-hospital mortality. Pediatr 1998; 101: 963-969
4. Jenkins KJ, Newburger JW, Lock JE, et al. In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload. Pediatr 1995; 95: 323-330
5. Sollano JA, Gelijns AC, Moskowitz AJ, et al. Volume-outcome relationships in cardiovascular operations: New York State, 1990-1995. J Thorac Cardiovasc Surg 1999; 117: 419-428
6. Hasan A, Pozzi M, Hamilton JRL. New surgical procedures: can we minimise the learning curve? Br Med J 2000; 320: 171-173
7. Odegard KC, Modest SA, Laussen PC. A survey of parental satisfaction during parent present induction of anaesthesia for children undergoing cardiovascular surgery. Paediatr Anaesth 2002; 12: 261-266
8. Russell IA, Miller Hance WC, Gregory G, et al. The safety and efficacy of sevoflurane anesthesia in infants and children with congenital heart disease. Anesth Analg 2001; 92: 1152-1158
9. Rosenthal DN, Friedman AH, Kleinman CS, et al. Thromboembolic complications after Fontan operations. Circulation 1995; 92: II287-II293
10. Booker PD. Editorial: Opioids in paediatric cardiac anaesthesia. Br J Anaesth 2000; 84: 547-549
11. Duncan HP, Cloote A, Weir PM, et al. Reducing stress responses in the pre-bypass phase of open heart surgery in infants and young children: a comparison of different fentanyl doses. Br J Anaesth 2000; 84: 556-564
12. Davis PJ, Wilson AS, Siewers RD, et al. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair. Anesth Analg 1999; 89: 904-908
13. Ahonen J, Olkkola KT, Hynynen M, et al. Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery. Br J Anaesth 2000; 85: 533-540
14. Koren G, Crean P, Klein J, et al. Sequestration of fentanyl by the cardiopulmonary bypass (CPBP). Eur J Clin Pharmacol 1984; 27: 51-56
15. Lake CL. Fast tracking the paediatric cardiac surgical patient. Paediatr Anaesth 2000; 10: 231-236
16. Peterson KL, DeCampli WM, Pike NA, et al. A report of two hundred twenty cases of regional anesthesia in pediatric cardiac surgery. Anesth Analg 2000; 90: 1014-1019
17. Miller BE, Tosone SR, Tam VK, et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 1998; 66: 535-540
18. Alvarez JM, Jackson LR, Chatwin C, Smolich JJ. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg 2001; 122: 457-463
19. Codispoti M, Mankad PS. Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice. Perfusion 2000; 15: 191-201
20. Carrel TP, Schwanda M, Vogt PR, Turina MI. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high dose regimen only. Ann Thorac Surg 1998; 66: 153-158
21. Coon PD, Rychik J, Novello RT, et al. Thrombus formation after the Fontan operation. Ann Thorac Surg 2001; 71: 1990-1994
22. Plessis AJ du, Jonas RA, Wypij D, et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg 1997; 114: 991-1001
23. Hickey PR. Neurologic sequelae associated with deep hypothermic circulatory arrest. Ann Thorac Surg 1998; 65: S65-S69
24. Sakamoto T, Zurakowski D, Duebener LF, et al. Combination of alpha-stat strategy and hemodilution exacerbates neurologic injury in a survival piglet model with deep hypothermic circulatory arrest. Ann Thorac Surg 2002; 73: 180-189
25. Kurth CD, O'Rourke MM, O'Hara IB. Comparison of pH-stat and alpha-stat cardiopulmonary bypass on cerebral oxygenation and blood flow in relation to hypothermic circulatory arrest in piglets. Anesthesiology 1998; 89: 110-118
26. Bellinger DC, Jonas RA, Rappaport LA, et al. Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med 1995; 332: 549-555
27. Kirkham FJ. Recognition and prevention of neurological complications in pediatric cardiac surgery. Pediatr Cardiol 1998; 19: 331-345
28. Pua HL, Bissonnette B. Cerebral physiology in paediatric cardiopulmonary bypass. Can J Anaesth 1998; 45: 960-978
29. Forbess JM, Visconti KJ, Bellinger DC, et al. Neurodelopmental outcomes after biventricular repair of congenital heart defects. J Thorac Cardiovasc Surg 2002; 123: 631-639
30. Kurth CD, O'Rourke MM, O'Hara IB, Uher B. Brain cooling efficiency with pH-stat and alpha-stat cardiopulmonary bypass in newborn pigs. Circulation 1997; 96: 359-363
31. Allen BS, Rahman S, Ilbawi MN, et al. Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. Ann Thorac Surg 1997; 64: 1381-1388
32. Zimmerman AA, Burrows FA, Jonas RA, Hickey PR. The limits of detectable cerebral perfusion by transcranial Doppler sonography in neonates undergoing deep hypothermic low-flow cardiopulmonary bypass. J Thorac Cardiovasc Surg 1997; 114: 594-600
33. Nollert G, Sperling J, Sakamoto T, et al. Higher hematocrit improves liver blood flow and metabolism during cardiopulmonary bypass in piglets. Thorac Cardiovasc Surg 2001; 49: 226-230
34. Duebener LF, Sakamoto T, Hatsuoka S, et al. Effects of hematocrit on cerebral microcirculation and tissue oxygenation during deep hypothermic bypass. Circulation 2001; 104: I-260-I-264
35. Bronicki RA, Backer CL, Baden HP, et al. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2000; 69: 1490-1495
36. Volk T, Schmutzler M, Engelhardt L, et al. Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass. Crit Care Med 2001; 29: 2137-2142
37. Azab SR El, Rosseel PM, Lange JJ de, et al. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 2002; 88: 496-501
38. Mott AR, Fraser CD Jr, Kusnoor AV, et al. The effect of short-term prophylactic methylprednisolone on the incidence and severity of post-pericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass. J Am Coll Cardiol 2001; 37: 1700-1706
39. Turkoz A, Cigli A, But K, et al. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery. J Cardiothorac Vasc Anesth 2001; 15: 603-610
40. Schurr UP, Zund G, Hoerstrup SP, et al. Preoperative administration of steroids: influence on adhesion molecules and cytokines after cardiopulmonary bypass. Ann Thorac Surg 2001; 72: 1316-1320
41. Chaney MA. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest 2002; 121: 921-931
42. Langley SM, Chal PJ, Jaggers JJ, Ungerleider RM. Preoperative high dose methylprednisolone attenuates the cerebral response to deep hypothermic circulatory arrest. Eur J Cardiothorac Surg 2000; 17: 279-286
43. Shum-Tim D, Tchervenkov CI, Jamal AM, et al. Systemic steroid pretreatment improves cerebral protection after circulatory arrest. Ann Thorac Surg 2001; 72: 1465-1471
44. Kanellopoulos GK, Kato H, Wu Y, et al. Neuronal cell death in the ischemic spinal cord. Ann Thorac Surg 1997; 64: 1279-1285
45. Naik SK, Knight A, Elliott M. A prospective randomized study of a modifed technique of ultrafiltration during pediatric open-heart surgery. Circulation 1991; 84: III422-III431
46. Friesen RH, Campbell DN, Clarke DR, Tornabene MA. Modified ultrafiltration attentuates dilutional coagulopathy in pediatric open heart operations. Ann Thorac Surg 1997; 64: 1787-1789
47. Draaisma AM, Hazekamp MG, Frank M, et al. Modified ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgery. Ann Thorac Surg 1997; 64: 521-525
48. Yndgaard S, Andersen LW, Andersen C, et al. The effect of modified ultrafiltration on the amount of circulating endotoxins in children undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14: 399-401
49. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993; 56: 1518-1522
50. Kameyama T, Ando F, Okamoto F, et al. The effect of modified ultrafiltration in pediatric open heart surgery. Ann Thorac Cardiovasc Surg 2000; 6: 19-26
51. Thompson LD, McElhinney DB, Findlay P, et al. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2001; 122: 209-211
52. Maluf MA, Mangia C, Silva C, et al. Conventional and conventional plus modified ultrafiltration during cardiac surgery in high-risk congenital heart disease. J Cardiovasc Surg (Torino) 2002; 42: 465-473
53. Wang MJ, Chiu IS, Hsu CM, et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg 1996; 61: 651-656
54. Ramamoorthy C, Lynn AM. Con: The use of modified ultrafiltration during pediatric cardiovascular surgery is not a benefit. J Cardiothorac Vasc Anesth 1998; 12: 483-485
55. Rosen DA, Morris JL, Rosen KR, et al. Analgesia for pediatric thoracostomy tube removal. Anesth Analg 2000; 90: 1025-1028